Search the MBS

Characterisation of germline gene variants, including copy number variation where appropriate, requested by a specialist or consultant physician:

(a) in genes associated with breast, ovarian, fallopian tube or primary peritoneal cancer, which may include the following genes:

(i) BRCA1 or BRCA2;

(ii) STK11, PTEN, CDH1, PALB2 and TP53; and

(b) in a patient:

(i) who has a biological relative who has had a pathogenic or likely pathogenic gene variant identified in one or more of the genes mentioned in paragraph (a); or

(ii) who has not previously received a service to which item 73295, 73296 or 73302 applies

Once per variant

Fee: $400.00 Benefit: 75% = $300.00 85% = $340.00

(See para PN.0.23 of explanatory notes to this Category)

• Previous - Item 73296
• Next - Item 73298